You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for Patent: 10,265,265

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,265,265 protect, and when does it expire?

Patent 10,265,265 protects WYNZORA and is included in one NDA.

This patent has nineteen patent family members in fourteen countries.

Summary for Patent: 10,265,265

Title:	Topical composition
Abstract:	A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analog and at least one corticosteroid.
Inventor(s):	Wheeler; Derek (Leatherhead, GB), Steele; David F. (Leatherhead, GB), Georgiou; Michelle (Leatherhead, GB), Sindet-Pedersen; Steen (Leatherhead, GB)
Assignee:	DRUG DELIVERY SOLUTIONS LIMITED (Leatherhead, Surrey, GB)
Application Number:	12/076,248
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 10,265,265

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mc2	WYNZORA	betamethasone dipropionate; calcipotriene	CREAM;TOPICAL	213422-001	Jul 20, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,265,265

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	07251094	Mar 15, 2007
United Kingdom	0723728.2	Dec 4, 2007

International Family Members for US Patent 10,265,265

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	065740	⤷ Sign Up
Austria	E516797	⤷ Sign Up
Australia	2008224704	⤷ Sign Up
Canada	2680405	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.